Training and follow-up for cancer patients receiving chemotherapy to prevent oral mucositis
The Effect of Training and Follow-up Given to Cancer Patients Receiving Chemotherapy According to the Neuman Systems Model
This study is testing a training program to help cancer patients on chemotherapy manage and reduce mouth sores so they can feel more comfortable during treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 94 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Ataturk University Academic / other |
| Drugs / interventions | chemotherapy, methotrexate |
| Locations | 1 site (Erzurum, Center) |
| Trial ID | NCT05991544 on ClinicalTrials.gov |
What this trial studies
This study aims to prevent or reduce the severity of oral mucositis in cancer patients undergoing chemotherapy by providing training based on the Neuman Systems Model. The intervention includes education on symptom management, coaching, and follow-up care to enhance patients' self-efficacy and coping abilities. By systematically evaluating and addressing the side effects of chemotherapy, the study seeks to improve patients' quality of life and comfort. The training program is designed to empower patients through knowledge and support, ultimately fostering better participation in their treatment processes.
Who should consider this trial
Good fit: Ideal candidates for this study are cancer patients receiving chemotherapy who are capable of using the internet and have at least a primary education level.
Not a fit: Patients who are illiterate or lack internet access may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life for cancer patients by reducing the incidence and severity of oral mucositis.
How similar studies have performed: Previous studies have shown that structured health education can effectively support cancer patients in managing treatment side effects, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Receiving chemotherapy treatment No mental or communication problems, Volunteering to participate in research. having internet, Having at least primary education level, Being able to use smart phone and internet. Being on treatment that causes methotrexate, Cispilatin, Cyclophoshamide, 5-fluorouracil group oral mucositis. - Exclusion Criteria: lack of internet illiteracy -
Where this trial is running
Erzurum, Center
- Atatürk university nursing faculty — Erzurum, Center, Turkey (Recruiting)
Study contacts
- Principal investigator: Gülcan B.TURAN — Firat University
- Study coordinator: Gülcan B.TURAN
- Email: glcnbah@hotmail.com
- Phone: 05065576086
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.